Researchers have proposed a novel integrated framework to understand the complex progression of autoimmune skin diseases. A ...

While interested in CAR-T therapies’ potential to achieve durable, drug-free remission in serious autoimmune conditions, the ...

Both autoimmune and autoinflammatory diseases (AIDs) are characterised by bouts of hyperactivation of immune reactions ...

Picture this: a huge house is being guarded by multiple security guards. Now imagine your body is that house, and the ...

At Web Summit Qatar, AI-powered biotech startups describe how automation, data, and gene editing are filling labor gaps in ...

A genetics‑guided drug, compound 6, targets CARD9 to subtly calm gut inflammation in Crohn’s disease, pointing to safer, ...

RNA-based medicine is about to take a huge leap forward thanks to the discovery of extremely short RNA fragments with important anti-inflammatory properties. Professor Michael Gantier's latest ...

The deal gets Lilly access to Orna’s in vivo CAR T technology. The biotech’s lead asset, which has yet to start clinical ...

Northwestern Medicine scientists in the laboratory of Stephen Miller, Ph.D., professor emeritus of Microbiology–Immunology, have identified the cellular and molecular mechanisms required for the ...

By Christy Santhosh Jan 29 (Reuters) - Drugmaker Eli Lilly is partnering with Repertoire Immune Medicines in a deal worth up ...

The deal underscores a broader shift in autoimmune drug development toward therapies that aim to reprogram disease-driving ...

Insilico Medicine ("Insilico", 03696.HK), a clinical-stage biotechnology company driven by generative artificial intelligence (AI), China Medical System Holdings Limited ("CMS", 867.HK/8A8.SG), an ...